Anonymization and De-Identification Standards for Shared Clinical Datasets
Anonymization and De-Identification Standards for Shared Clinical Datasets Anonymization and De-Identification Standards for Shared Clinical Datasets In the realm of pharma clinical trials, the significance of data integrity and patient confidentiality cannot be overstated. As clinical trials strive for transparency and data sharing, the concepts of anonymization and de-identification play pivotal roles in the ethical…
Read More “Anonymization and De-Identification Standards for Shared Clinical Datasets” »